To understand whether the expression of a mutated version of the SF3B1 gene has an apparent impact on cellular response to the MDM2 inhibitors, the LC50 values of RG7388 for the p53 functional (TP53WT) CLL samples were plotted against the SF3B1 status. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.